| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine (R.W.G., C.D.M., G.J.M., M.W.S.), Harborview Medical Center, University of Washington, Seattle, Washington 98104; and Department of Medicine (J.O., R.S.F., D.E.C.), Veterans Affairs Puget Sound Healthcare System, Seattle, Washington 98108
Address all correspondence and requests for reprints to: Michael W. Schwartz, M.D., Harborview Medical Center, Division of Endocrinology, 325 Ninth Avenue, Box 359657, Seattle, Washington 98104. E-mail: mschwart{at}u.washington.edu.
Plasma levels of the orexigenic hormone, ghrelin, decrease rapidly on nutrient ingestion and yet are paradoxically elevated in rats with hyperphagia induced by streptozotocin-induced diabetes (STZ-DM). In the current work, we investigated the mechanisms underlying the relationships among uncontrolled diabetes, food intake, and plasma ghrelin concentrations in an effort to clarify whether increased ghrelin signaling contributes to diabetic hyperphagia. Whereas food intake did not increase until d 3 after STZ administration, plasma ghrelin levels were increased by more than 2-fold (P < 0.05) on d 1. As hyperphagia developed, however, plasma ghrelin levels declined steadily. Because this reduction of plasma ghrelin levels was reversed by matching food intake of STZ-DM rats to that of nondiabetic controls, our results demonstrated that the effect of uncontrolled diabetes to increase plasma ghrelin levels is partially offset by hyperphagic feeding. In addition, we found that although intragastric nutrient infusion rapidly and comparably decreased plasma ghrelin levels in both groups (by 4649%; P < 0.05), this effect was short lived in STZ-DM rats relative to nondiabetic controls (60 min vs. 120 min; P < 0.05). We further demonstrated that in rats with STZ-DM, food intake increased by 357% (P < 0.05) in response to intracerebroventricular administration of ghrelin at a dose that was subthreshold for feeding effects in nondiabetic controls. Collectively, these findings demonstrate that uncontrolled diabetes increases both circulating ghrelin levels and behavioral sensitivity to ghrelin. Although plasma ghrelin levels fall in response to hyperphagic feeding, these findings support the hypothesis that increased ghrelin signaling contributes to the pathogenesis of diabetic hyperphagia.
This article has been cited by other articles:
![]() |
H. Ariga, K. Imai, C. Chen, C. Mantyh, T. N. Pappas, and T. Takahashi Does ghrelin explain accelerated gastric emptying in the early stages of diabetes mellitus? Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R1807 - R1812. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Foster-Schubert, J. Overduin, C. E. Prudom, J. Liu, H. S. Callahan, B. D. Gaylinn, M. O. Thorner, and D. E. Cummings Acyl and Total Ghrelin Are Suppressed Strongly by Ingested Proteins, Weakly by Lipids, and Biphasically by Carbohydrates J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1971 - 1979. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Lechuga-Sancho, A. I. Arroba, L. M. Frago, C. Garcia-Caceres, A. D.-R. de Celix, J. Argente, and J. A. Chowen Reduction in the Number of Astrocytes and Their Projections Is Associated with Increased Synaptic Protein Density in the Hypothalamus of Poorly Controlled Diabetic Rats Endocrinology, November 1, 2006; 147(11): 5314 - 5324. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Arafat, F. H. Perschel, B. Otto, M. O. Weickert, H. Rochlitz, C. Schofl, J. Spranger, M. Mohlig, and A. F. H. Pfeiffer Glucagon Suppression of Ghrelin Secretion Is Exerted at Hypothalamus-Pituitary Level J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3528 - 3533. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Gelling Diabetic Hyperphagia--Ghrelin in the Driver's Seat. Endocrinology, June 1, 2006; 147(6): 2631 - 2633. [Full Text] [PDF] |
||||
![]() |
J. Dong, T. L. Peeters, B. De Smet, D. Moechars, C. Delporte, P. Vanden Berghe, B. Coulie, M. Tang, and I. Depoortere Role of Endogenous Ghrelin in the Hyperphagia of Mice with Streptozotocin-Induced Diabetes Endocrinology, June 1, 2006; 147(6): 2634 - 2642. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. O. Mundinger, D. E. Cummings, and G. J. Taborsky Jr Direct Stimulation of Ghrelin Secretion by Sympathetic Nerves Endocrinology, June 1, 2006; 147(6): 2893 - 2901. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Tritos and E. G. Kokkotou The Physiology and Potential Clinical Applications of Ghrelin, a Novel Peptide Hormone Mayo Clin. Proc., May 1, 2006; 81(5): 653 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Griffen, K. Oostema, K. L. Stanhope, J. Graham, D. M. Styne, N. Glaser, D. E. Cummings, M. H. Connors, and P. J. Havel Administration of Lispro Insulin with Meals Improves Glycemic Control, Increases Circulating Leptin, and Suppresses Ghrelin, Compared with Regular/NPH Insulin in Female Patients with Type 1 Diabetes J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 485 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsubone, T. Masaki, I. Katsuragi, K. Tanaka, T. Kakuma, and H. Yoshimatsu Leptin downregulates ghrelin levels in streptozotocin-induced diabetic mice Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1703 - R1706. [Abstract] [Full Text] [PDF] |
||||
![]() |
M A Arafat, B Otto, H Rochlitz, M Tschop, V Bahr, M Mohlig, S Diederich, J Spranger, and A F H Pfeiffer Glucagon inhibits ghrelin secretion in humans Eur. J. Endocrinol., September 1, 2005; 153(3): 397 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Govoni, R De Iasio, C Cocco, A Parmeggiani, G Galeati, U Pagotto, C Brancia, M Spinaci, C Tamanini, R Pasquali, et al. Gastric immunolocalization and plasma profiles of acyl-ghrelin in fasted and fasted-refed prepuberal gilts J. Endocrinol., September 1, 2005; 186(3): 505 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Overduin, R. S. Frayo, H. J. Grill, J. M. Kaplan, and D. E. Cummings Role of the Duodenum and Macronutrient Type in Ghrelin Regulation Endocrinology, February 1, 2005; 146(2): 845 - 850. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |